TO STOP OR NOT TO STOP – THAT IS THE QUESTION?
You have had aHUS. The type of aHUS caused by uncontrolled complement, not the other type. You got access to a…
You have had aHUS. The type of aHUS caused by uncontrolled complement, not the other type. You got access to a…
The long anticipated KDIGO Guidelines from the Controversies Conference held in Florence in September 2022 are now published. The report can…
Pregnancy is a common trigger of aHUS, this can impact on someone who is predisposed or related to someone predisposed to…
In September last year a group of aHUS patients and parent/carers met with FDA and told them about aHUS. A summary…
A cure for aHUS would mean an individual would be at no risk of the disease again. Patients ask Will there…
It’s 2024. A New Year.This year around the world about 4000 people will newly onset with the primary form of aHUS.…
Last year at this time Global Action published an article recording a conversation we had with ChatGPT ( an AI thing)…
For aHUS patients stopping eculizumab (or even Ravulizumab) treatment is an important but emotive issue. Having had the treatment when seriously…
Algorithms to diagnose aHUS apart from other syndromes of TMA exist, but why do these tools with problem solving steps seem under-utilized?